EP4353091A3 - Aerosolierbare formulierung - Google Patents

Aerosolierbare formulierung Download PDF

Info

Publication number: EP4353091A3
Authority: EP; European Patent Office
Prior art keywords: aerosolisable formulation; aerosolisable; formulation; nicotine; water
Prior art date: 2018-11-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP24152849.6A

Other languages

English (en)

French (fr)

Other versions

EP4353091B1 (de

EP4353091A2 (de

Inventor

Ross CABOT

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nicoventures Trading Ltd

Original Assignee

Nicoventures Trading Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-11-01

Filing date

2019-10-31

Publication date

2024-07-10

2019-10-31 Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd

2024-04-17 Publication of EP4353091A2 publication Critical patent/EP4353091A2/de

2024-07-10 Publication of EP4353091A3 publication Critical patent/EP4353091A3/de

2025-08-06 Application granted granted Critical

2025-08-06 Publication of EP4353091B1 publication Critical patent/EP4353091B1/de

Status Active legal-status Critical Current

2039-10-31 Anticipated expiration legal-status Critical

Links

Classifications

- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/05—Devices without heating means
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/10—Devices using liquid inhalable precursors

Landscapes

Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Medicinal Preparation (AREA)
General Preparation And Processing Of Foods (AREA)
Jellies, Jams, And Syrups (AREA)
Manufacture Of Tobacco Products (AREA)
Colloid Chemistry (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

EP24152849.6A 2018-11-01 2019-10-31 Aerosolierbare formulierung Active EP4353091B1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB1817865.7A GB201817865D0 (en)	2018-11-01	2018-11-01	Aerosolisable formulation
PCT/GB2019/053092 WO2020089637A1 (en)	2018-11-01	2019-10-31	Aerosolisable formulation
EP19798365.3A EP3873245B1 (de)	2018-11-01	2019-10-31	Aerosolfähige formulierung

Related Parent Applications (2)

Application Number	Title	Priority Date	Filing Date
EP19798365.3A Division EP3873245B1 (de)	2018-11-01	2019-10-31	Aerosolfähige formulierung
EP19798365.3A Division-Into EP3873245B1 (de)	2018-11-01	2019-10-31	Aerosolfähige formulierung

Publications (3)

Publication Number	Publication Date
EP4353091A2 EP4353091A2 (de)	2024-04-17
EP4353091A3 true EP4353091A3 (de)	2024-07-10
EP4353091B1 EP4353091B1 (de)	2025-08-06

Family

ID=64655353

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP24152849.6A Active EP4353091B1 (de)	2018-11-01	2019-10-31	Aerosolierbare formulierung
EP19798365.3A Active EP3873245B1 (de)	2018-11-01	2019-10-31	Aerosolfähige formulierung

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EP19798365.3A Active EP3873245B1 (de)	2018-11-01	2019-10-31	Aerosolfähige formulierung

Country Status (16)

Country	Link
US (1)	US20210386110A1 (de)
EP (2)	EP4353091B1 (de)
JP (1)	JP7703445B2 (de)
KR (1)	KR102684717B1 (de)
CN (1)	CN113015444A (de)
AU (1)	AU2019371079B2 (de)
BR (1)	BR112021008556A2 (de)
CA (1)	CA3118051A1 (de)
ES (1)	ES2984536T3 (de)
GB (1)	GB201817865D0 (de)
IL (1)	IL282523A (de)
MX (1)	MX2021005123A (de)
MY (1)	MY204015A (de)
PL (2)	PL4353091T3 (de)
UA (1)	UA128040C2 (de)
WO (1)	WO2020089637A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201817860D0 (en)	2018-11-01	2018-12-19	Nicoventures Trading Ltd	Aerosolised formulation
GB201817863D0 (en)	2018-11-01	2018-12-19	Nicoventures Trading Ltd	Aerosolisable formulation
GB201817859D0 (en) *	2018-11-01	2018-12-19	Nicoventures Trading Ltd	Aerosolisable formulation
GB202013489D0 (en)	2020-08-27	2020-10-14	Nicoventures Holdings Ltd	Consumable
US11771132B2 (en)	2020-08-27	2023-10-03	Rai Strategic Holdings, Inc.	Atomization nozzle for aerosol delivery device
US11771136B2 (en)	2020-09-28	2023-10-03	Rai Strategic Holdings, Inc.	Aerosol delivery device
IT202100022172A1 (it) *	2021-08-23	2023-02-23	Natural Acad S R L	Composizione liquida medicale per somministrazione aerea
KR20240028723A (ko) *	2022-08-25	2024-03-05	주식회사 케이티앤지	산을 포함하는 흡연물품

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040034068A1 (en) *	2002-06-03	2004-02-19	Woodcock Washburn Llp	New formulation and use thereof
DE102015117811A1 (de) *	2015-10-20	2017-04-20	Chv Pharma Gmbh & Co. Kg	Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
WO2019086858A1 (en) *	2017-11-01	2019-05-09	British American Tobacco (Investments) Limited	Aerosolisable formulation
EP3574902A1 (de) *	2018-06-01	2019-12-04	Yatzz Limited	Nikotinformulierung und modus der abgabe

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0462094U (de) *	1990-10-09	1992-05-27
AU717600B2 (en) *	1993-07-26	2000-03-30	Mcneil Ab	Improved nicotine lozenge and therapeutic method for smoking cessation
US20080138399A1 (en) *	1999-07-16	2008-06-12	Aradigm Corporation	Dual release nicotine formulations, and systems and methods for their use
US20040156792A1 (en) *	2002-12-31	2004-08-12	Nektar Therapeutics	Pharmaceutical formulation with an insoluble active agent
SE0104388D0 (sv) *	2001-12-27	2001-12-27	Pharmacia Ab	New formulation and use and manufacture thereof
US20030159702A1 (en) *	2002-01-21	2003-08-28	Lindell Katarina E.A.	Formulation and use manufacture thereof
SE0300520D0 (sv) *	2003-02-28	2003-02-28	Pharmacia Ab	A container comprising nicotine and the use and manufacture thereof
US20070267033A1 (en) *	2006-02-09	2007-11-22	Philip Morris Usa Inc.	Gamma cyclodextrin flavoring-release additives
CN101583354A (zh) *	2006-12-01	2009-11-18	阿拉迪姆公司	用于终止烟草使用的系统
GB0700889D0 (en)	2007-01-17	2007-02-21	British American Tobacco Co	Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
US20080286340A1 (en) *	2007-05-16	2008-11-20	Sven-Borje Andersson	Buffered nicotine containing products
GB0918129D0 (en) *	2009-10-16	2009-12-02	British American Tobacco Co	Control of puff profile
US9333229B2 (en) *	2013-10-16	2016-05-10	William Bjorncrantz	Winterized crude cannabis extracts and methods of preparation and use
TWI664918B (zh)	2014-05-21	2019-07-11	瑞士商菲利浦莫里斯製品股份有限公司	可感應加熱的菸草產品
GB2528673B (en) *	2014-07-25	2020-07-01	Nicoventures Holdings Ltd	Aerosol provision system
GB201413835D0 (en)	2014-08-05	2014-09-17	Nicoventures Holdings Ltd	Electronic vapour provision system
GB2535427A (en)	2014-11-07	2016-08-24	Nicoventures Holdings Ltd	Solution
US20160198759A1 (en) *	2015-01-13	2016-07-14	Zip Llc	E-cigarette or vaping fluid
US20170325494A1 (en) *	2016-05-16	2017-11-16	Lunatech, Llc	Liquid composition containing nicotine from non-tobacco source for use with electronic vaporizing devices
US12114688B2 (en) *	2017-10-24	2024-10-15	Rai Strategic Holdings, Inc.	Method for formulating aerosol precursor for aerosol delivery device
US20190328040A1 (en) *	2018-04-30	2019-10-31	Zayd Abdulfuhah Turbi	Systems and Methods for Buffered Aerosol Drug Delivery
GB201817859D0 (en)	2018-11-01	2018-12-19	Nicoventures Trading Ltd	Aerosolisable formulation

2018
- 2018-11-01 GB GBGB1817865.7A patent/GB201817865D0/en not_active Ceased
2019
- 2019-10-31 MX MX2021005123A patent/MX2021005123A/es unknown
- 2019-10-31 JP JP2021523256A patent/JP7703445B2/ja active Active
- 2019-10-31 CA CA3118051A patent/CA3118051A1/en active Pending
- 2019-10-31 AU AU2019371079A patent/AU2019371079B2/en active Active
- 2019-10-31 WO PCT/GB2019/053092 patent/WO2020089637A1/en not_active Ceased
- 2019-10-31 CN CN201980075317.2A patent/CN113015444A/zh active Pending
- 2019-10-31 KR KR1020217012916A patent/KR102684717B1/ko active Active
- 2019-10-31 EP EP24152849.6A patent/EP4353091B1/de active Active
- 2019-10-31 US US17/290,319 patent/US20210386110A1/en active Pending
- 2019-10-31 BR BR112021008556-4A patent/BR112021008556A2/pt unknown
- 2019-10-31 PL PL24152849.6T patent/PL4353091T3/pl unknown
- 2019-10-31 EP EP19798365.3A patent/EP3873245B1/de active Active
- 2019-10-31 ES ES19798365T patent/ES2984536T3/es active Active
- 2019-10-31 PL PL19798365.3T patent/PL3873245T3/pl unknown
- 2019-10-31 UA UAA202102224A patent/UA128040C2/uk unknown
- 2019-10-31 MY MYPI2021002221A patent/MY204015A/en unknown
2021
- 2021-04-21 IL IL282523A patent/IL282523A/en unknown

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040034068A1 (en) *	2002-06-03	2004-02-19	Woodcock Washburn Llp	New formulation and use thereof
DE102015117811A1 (de) *	2015-10-20	2017-04-20	Chv Pharma Gmbh & Co. Kg	Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
WO2019086858A1 (en) *	2017-11-01	2019-05-09	British American Tobacco (Investments) Limited	Aerosolisable formulation
EP3574902A1 (de) *	2018-06-01	2019-12-04	Yatzz Limited	Nikotinformulierung und modus der abgabe

Also Published As

Publication number	Publication date
UA128040C2 (uk)	2024-03-20
PL4353091T3 (pl)	2025-11-24
MY204015A (en)	2024-07-31
IL282523A (en)	2021-06-30
AU2019371079B2 (en)	2022-07-14
EP4353091B1 (de)	2025-08-06
AU2019371079A1 (en)	2021-05-27
JP7703445B2 (ja)	2025-07-07
KR20210075107A (ko)	2021-06-22
MX2021005123A (es)	2021-06-15
GB201817865D0 (en)	2018-12-19
EP3873245B1 (de)	2024-02-28
EP4353091A2 (de)	2024-04-17
NZ775331A (en)	2024-09-27
PL3873245T3 (pl)	2024-07-29
CA3118051A1 (en)	2020-05-07
ES2984536T3 (es)	2024-10-29
BR112021008556A2 (pt)	2021-08-03
JP2022506094A (ja)	2022-01-17
CN113015444A (zh)	2021-06-22
US20210386110A1 (en)	2021-12-16
WO2020089637A1 (en)	2020-05-07
EP3873245A1 (de)	2021-09-08
KR102684717B1 (ko)	2024-07-11

Legal Events

Date	Code	Title	Description
2024-03-15	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2024-03-15	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED
2024-04-17	AC	Divisional application: reference to earlier application	Ref document number: 3873245 Country of ref document: EP Kind code of ref document: P
2024-04-17	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2024-06-07	PUAL	Search report despatched	Free format text: ORIGINAL CODE: 0009013
2024-07-10	AK	Designated contracting states	Kind code of ref document: A3 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2024-07-10	RIC1	Information provided on ipc code assigned before grant	Ipc: A24B 15/167 20200101AFI20240531BHEP
2025-01-01	P01	Opt-out of the competence of the unified patent court (upc) registered	Free format text: CASE NUMBER: APP_62485/2024 Effective date: 20241122
2025-01-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2025-02-05	17P	Request for examination filed	Effective date: 20241227
2025-03-02	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2025-03-02	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2025-04-02	INTG	Intention to grant announced	Effective date: 20250303
2025-06-25	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2025-07-04	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2025-07-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2025-08-06	AC	Divisional application: reference to earlier application	Ref document number: 3873245 Country of ref document: EP Kind code of ref document: P
2025-08-06	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2025-08-06	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2025-08-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2025-08-27	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2025-08-28	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602019073968 Country of ref document: DE
2025-12-10	REG	Reference to a national code	Ref country code: NL Ref legal event code: MP Effective date: 20250806
2026-01-08	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251206
2026-01-08	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20251021 Year of fee payment: 7
2026-01-09	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20251022 Year of fee payment: 7
2026-01-12	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251106
2026-01-12	REG	Reference to a national code	Ref country code: LT Ref legal event code: MG9D
2026-01-13	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251209
2026-01-14	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-01-14	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IT Payment date: 20251128 Year of fee payment: 7
2026-01-15	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-01-15	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20251030 Year of fee payment: 7
2026-01-16	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251107
2026-01-20	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-01-22	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-01-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-01-23	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: PL Payment date: 20251027 Year of fee payment: 7
2026-01-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20251106
2026-01-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-02-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 1820691 Country of ref document: AT Kind code of ref document: T Effective date: 20250806
2026-03-17	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-04-06	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-04-13	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-04-14	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-04-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806
2026-04-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250806

Publication	Publication Date	Title
EP4353091A3 (de)	2024-07-10	Aerosolierbare formulierung
MX2021005117A (es)	2021-06-15	Formulacion aerosolizable.
EP4696154A3 (de)	2026-04-15	Verfahren zur herstellung eines geformten schaums mit einem wirkstoff mit tabakbestandteil
WO2003095080A3 (en)	2004-02-12	Apparatus and method for creating a ready-to-use product from a concentrated form
WO2019147749A3 (en)	2019-09-19	Stabilized rsv f proteins and uses thereof
MX2021007624A (es)	2021-08-11	Formulacion de nicotina liquida.
MY201970A (en)	2024-03-27	Aerosolisable formulation
MX2019004341A (es)	2019-07-01	Metodos y sistemas para mejorar la estabilidad de la formulacion prevapor de un dispositivo de vapeo electronico.
MY206012A (en)	2024-11-25	Aerosolisable formulation
MY193486A (en)	2022-10-17	Novel 5 ' -inosinic acid dehydrogenase and method preparing 5'-inosinic acid using the same
MY208833A (en)	2025-05-31	Method and aqueous composition for preventing wildfire
MY203193A (en)	2024-06-13	Aerosolisable formulation
EP4245337A3 (de)	2023-12-27	Aerosolierbares gel
MX2020011504A (es)	2022-09-21	Composicion farmaceutica que comprende salbutamol.
WO2019147210A3 (en)	2019-08-29	Pressure-regulated balloon apparatus positioned in the cavity formed in the brain after surgery
NZ763603A (en)	2023-07-28	Flavoured vaporisable formulation
ZA202100040B (en)	2024-06-26	Aerosolisable formulation
AU2017370226A1 (en)	2019-08-01	Pharmaceutical composition containing insulin-like growth factor-2 and use thereof
EP4344546A3 (de)	2024-06-12	Fungizide mischung
WO2020046059A3 (ko)	2020-04-23	먼지 생성을 억제하는 방법, 토양안정제 조성물, 및 이를 포함하는 분무 장치
EP3815915A8 (de)	2021-10-27	Substrat mit einem markierungselement, behälter mit solch einem substrat und verfahren zur herstellung solch eines substrats mit einem markierungselement
WO2019195355A9 (en)	2019-12-05	Tablet or composition having n-acyl ethanolamine and cannabinoid
WO2018144870A8 (en)	2019-09-06	Compositions and methods for inhibiting reticulon 4
MX2023006327A (es)	2023-06-12	Composiciones de tratamiento liquidas que comprenden particulas de suministro basadas en material de colofonia vegetal.
ZA202006210B (en)	2024-12-18	Plant expression enhancer